Suchergebnisse - "Enßle, Julius C"

PubPharm (15)

1

Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy

enthalten in: Cancer cell | 2024

von Phelan, J. | Scheich, S. | Choi, J. | +30

2

Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients

enthalten in: Leukemia | 2024

von Enssle, J. | Campe, J. | Moter, A. | +18

3

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML

enthalten in: Annals of hematology | 2023

von Cremer, A. | Enssle, J. | Pfaff, S. | +8

4

Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy : a real-world registry experience

enthalten in: British journal of cancer | 2023

von Enßle, J. | Wolf, S. | Scheich, S. | +31

5

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML

enthalten in: Annals of hematology | 2023

von Cremer, A. | Enssle, J. | Pfaff, S. | +8

6

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML

enthalten in: Annals of hematology | 2023

von Cremer, A. | Enssle, J. | Pfaff, S. | +8

7

Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas

enthalten in: Cancer discovery | 2023

von Scheich, S. | Chen, J. | Liu, J. | +26

8

Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma

enthalten in: Cancer cell | 2022

von Enssle, J. | Campe, J. | Büchel, S. | +15

9

The proteogenomic subtypes of acute myeloid leukemia

enthalten in: Cancer cell | 2022

von Jayavelu, A. | Wolf, S. | Buettner, F. | +41

10

Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma

enthalten in: Blood | 2022

von Enßle, J. | Campe, J. | Schwenger, A. | +14

CommentIn: Blood. 2022 Jan 6;139(1):12-13. - PMID 34989773